Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
British Journal of Clinical Pharmacology
|
September 27, 2024
Modelling antibody dynamics in humans after different Ad26.COV2.S vaccination schemes
Anna Dari, Juan José Pérez Ruixo, Mathieu Le Gars, et al.
Immunological Reviews
|
June 11, 2022
Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine
Mathieu Le Gars, Jenny Hendriks, Jerald Sadoff, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 9, 2016
Mechanisms of Invariant NKT Cell Activity in Restraining Bacillus anthracis Systemic Dissemination
Mathieu Le Gars, Michel Haustant, Maria Klezovich-Bénard, et al.
Medecine Sciences : M/S
|
June 15, 2017
[iNKT cells: potential therapeutic targets to fight anthrax]
Mathieu Le Gars, Michel Haustant, Maria Klezovich-Benard, et al.
Vaccine
|
February 2, 2023
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S: Results of a phase 1, randomized, double-blind, placebo-controlled COVID-19 vaccine trial in Japan
Yumi Tsuchiya, Hiroshi Tamura, Koji Fujii, et al.
Vaccine
|
August 9, 2024
Pre- and post-Ad26.COV2·S booster dose antibody levels predict COVID-19 disease risk
Sanne Roels, Matthias Bruckner, Jerald Sadoff, et al.
BMC Bioinformatics
|
March 23, 2021
CytoGLMM: conditional differential analysis for flow and mass cytometry experiments
Christof Seiler, Anne-Maud Ferreira, Lisa M Kronstad, et al.
Ebiomedicine
|
May 5, 2026
Early transcriptional responses following Ad26.COV2.S vaccination in individuals with prior SARS-CoV-2 infection
Veronica V Rezelj, Jeroen Tolboom, Nina Hertoghs, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 16, 2023
Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID-19 vaccine Ad26.COV2.S in humans
Anna Dari, Philippe Jacqmin, Yuki Iwaki, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 2012
Toll-like receptor 5 (TLR5), IL-1β secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing
Delphyne Descamps, Mathieu Le Gars, Viviane Balloy, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
British Journal of Clinical Pharmacology
|
September 27, 2024
Modelling antibody dynamics in humans after different Ad26.COV2.S vaccination schemes
Anna Dari, Juan José Pérez Ruixo, Mathieu Le Gars, et al.
Immunological Reviews
|
June 11, 2022
Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine
Mathieu Le Gars, Jenny Hendriks, Jerald Sadoff, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 9, 2016
Mechanisms of Invariant NKT Cell Activity in Restraining Bacillus anthracis Systemic Dissemination
Mathieu Le Gars, Michel Haustant, Maria Klezovich-Bénard, et al.
Medecine Sciences : M/S
|
June 15, 2017
[iNKT cells: potential therapeutic targets to fight anthrax]
Mathieu Le Gars, Michel Haustant, Maria Klezovich-Benard, et al.
Vaccine
|
February 2, 2023
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S: Results of a phase 1, randomized, double-blind, placebo-controlled COVID-19 vaccine trial in Japan
Yumi Tsuchiya, Hiroshi Tamura, Koji Fujii, et al.
Vaccine
|
August 9, 2024
Pre- and post-Ad26.COV2·S booster dose antibody levels predict COVID-19 disease risk
Sanne Roels, Matthias Bruckner, Jerald Sadoff, et al.
BMC Bioinformatics
|
March 23, 2021
CytoGLMM: conditional differential analysis for flow and mass cytometry experiments
Christof Seiler, Anne-Maud Ferreira, Lisa M Kronstad, et al.
Ebiomedicine
|
May 5, 2026
Early transcriptional responses following Ad26.COV2.S vaccination in individuals with prior SARS-CoV-2 infection
Veronica V Rezelj, Jeroen Tolboom, Nina Hertoghs, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 16, 2023
Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID-19 vaccine Ad26.COV2.S in humans
Anna Dari, Philippe Jacqmin, Yuki Iwaki, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 2012
Toll-like receptor 5 (TLR5), IL-1β secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing
Delphyne Descamps, Mathieu Le Gars, Viviane Balloy, et al.
Page
of 5